Alzheimers drug candidate may have potential for treating PD

2022 HD Family Education Day online

Join us on Facebook Live on Saturday, November 12, at 9:00 am MT for our annual Rocky Mountain Huntington’s Disease Family Education Day. You'll also be able to watch the event at www.movementdisordersfoundation.org.

Recorded on October 29 at Englewood Civic Center, the 2022 Family Education Day offers presentations by the region's leading physicians and medical experts on Huntington's Disease research and patient care: Emily Forbes, DO, MS & Rajeev Kumar, MD (research), Jennifer Medina, Ph.D (mindfulness), Marrisa Lafreniere, BS Instructor/Fellow, Neurology (genetic testing), David Marks, CLU, LUTCF (insurance planning) and more.

Co-presented by the HDSA Centers of Excellence at the University of Colorado and Rocky Mountain Movement Disorders Centers, the 2022 Family Education Day is free, but registration is recommended. Click here to register for the streamed event.

Colorado Gives Day is open for early giving!

One hundred percent (100%) of your Colorado Gives Day contribution to the Movement Disorders Foundation General Fund will be designated to the development of new programs and educational programming to support and serve individuals with movement disorders and their families. Contributions also can be designated to MDF Research Funding.

And don't forget the Colorado Gives Day $1 million Incentive Fund increases the value of every donation proportionally. Click here to make your donation today or on Colorado Gives Day, Tuesday, December 6.

Alzheimer’s drug candidate may have potential for treating Parkinson’s disease

A recent study published in Science Signaling identified a novel mechanism through which mutations in LRRK2 may cause the loss of dopamine neurons in Parkinson’s disease. Click here to read more.

Improving chorea control

Three-year data from Teva Pharmaceutical found that Austedo (deutetrabenazine) improved and maintained chorea control in those with Huntington's disease. The safety and tolerability was similar to that seen in a 12-week study. Click here to learn more.

The 2022 Rocky Mountain Huntington's Disease Family Education Day is underwritten in part by the generous support of Teva Pharmaceutical. Click here to learn more about Austedo.

Meet the MDF team

Member of the Board of Directors Sara Minott, MHA, NEA-BC

Vice President of Neurosciences at Swedish Medical Center Sara Minott brings to Movement Disorders Foundation more than 20 years of healthcare experience spanning clinical care, hospital operations, service-line strategy and business development. Click here to learn more about Sara and the entire MDF team.